Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
5,225
datasets available to search
ShareScore release 0.9.0
Dataset results
5,225 results for “moderation”
A Study of LCZ696 in Subjects With Mild and Moderate Hepatic Impairment Compared With Normal Healthy Volunteers
ClinicalTrials.gov study NCT01621633. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Effects of Early Exercise in Patients With Moderate to Severe Stroke.
ClinicalTrials.gov study NCT04241952. IPD Sharing: Not stated. Countries: 0. Publications: 1.
Study to Evaluate the Efficacy Safety and Tolerability of QR-421a in Subjects With RP Due to Mutations in Exon 13 of the USH2A Gene With Early to Moderate Vision Loss (Celeste)
ClinicalTrials.gov study NCT05176717. IPD Sharing: NO. Countries: 2. Publications: 0.
Real Life Remote Monitoring of Mild, Moderate and Severe Infectious Complications in IBD by Patient Reported Assessment
ClinicalTrials.gov study NCT04151420. IPD Sharing: YES. Countries: 1. Publications: 0.
Study of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis
ClinicalTrials.gov study NCT07298395. IPD Sharing: NO. Countries: 1. Publications: 0.
Bioequivalence Study of Pimecrolimus Cream, 1% and Elidel® Cream, 1% in Mild to Moderate Atopic Dermatitis
ClinicalTrials.gov study NCT03107611. IPD Sharing: Not stated. Countries: 3. Publications: 0.
Study of Efficacy of Carbamazepine in Therapy of Patients With Moderate Persistent and Severe Bronchial Asthma
ClinicalTrials.gov study NCT00153296. IPD Sharing: Not stated. Countries: 0. Publications: 1.
Safety and Tolerability of Zipsor® in Pediatric Subjects (Ages 12-17 Years) With Mild to Moderate Acute
ClinicalTrials.gov study NCT01982539. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Deep vs Moderate Block: Impact on Operating Conditions & Patient Satisfaction
ClinicalTrials.gov study NCT02794714. IPD Sharing: UNDECIDED. Countries: 0. Publications: 15.
Vunakizumab Combined With Recaticimab in Subjects With Moderate to Severe Plaque Psoriasis and Dyslipidemia
ClinicalTrials.gov study NCT07373847. IPD Sharing: YES. Countries: 0. Publications: 2.
A Study Investigating the Effect of EDP1815 in the Treatment of Mild, Moderate and Severe Atopic Dermatitis
ClinicalTrials.gov study NCT05121480. IPD Sharing: NO. Countries: 6. Publications: 0.
A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease
ClinicalTrials.gov study NCT06233461. IPD Sharing: YES. Countries: 24. Publications: 0.
International Clinical Trial to Evaluate Efficacy and Safety of Multiple Subcutaneous Injections of BCD-085 in Various Doses in Patients With Moderate to Severe Plaque Psoriasis
ClinicalTrials.gov study NCT02762994. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Pharmacokinetics, Safety and Efficacy of Nemolizumab in Participants With Moderate-to-Severe Atopic Dermatitis
ClinicalTrials.gov study NCT04921345. IPD Sharing: Not stated. Countries: 5. Publications: 0.
A Study of KY1005 in Patients With Moderate to Severe Atopic Dermatitis
ClinicalTrials.gov study NCT03754309. IPD Sharing: YES. Countries: 4. Publications: 0.
A Dosing and Efficacy Study of Intra-nasal Sufentanil for Moderate to Severe Pain
ClinicalTrials.gov study NCT01012999. IPD Sharing: NO. Countries: 1. Publications: 0.
Safety,Tolerability,Pharmacokinetics and Efficacy of CFZ533 in Moderate to Severe Myasthenia Gravis
ClinicalTrials.gov study NCT02565576. IPD Sharing: Not stated. Countries: 5. Publications: 0.
Study to Evaluate Adverse Events and Change in Disease Activity in Participants Between 18 to 75 Years of Age Treated With Subcutaneous (SC) Injections of ABBV-154 for Moderately to Severely Active Rh
ClinicalTrials.gov study NCT04888585. IPD Sharing: YES. Countries: 21. Publications: 0.
Andecaliximab as Add-On Therapy to a Tumor Necrosis Factor Inhibitor and Methotrexate Regimen in Adults With Moderately to Severely Active Rheumatoid Arthritis
ClinicalTrials.gov study NCT02862574. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Maraviroc in Patients With Moderate and Severe COVID-19
ClinicalTrials.gov study NCT04435522. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.